Amalgamated Bank’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$43K Hold
2,900
﹤0.01% 1861
2025
Q1
$52K Buy
2,900
+343
+13% +$6.15K ﹤0.01% 1791
2024
Q4
$45K Hold
2,557
﹤0.01% 1862
2024
Q3
$36K Hold
2,557
﹤0.01% 1945
2024
Q2
$21K Buy
2,557
+424
+20% +$3.48K ﹤0.01% 2103
2024
Q1
$16K Sell
2,133
-7,615
-78% -$57.1K ﹤0.01% 2239
2023
Q4
$88K Sell
9,748
-635
-6% -$5.73K ﹤0.01% 2045
2023
Q3
$93K Hold
10,383
﹤0.01% 2029
2023
Q2
$159K Buy
10,383
+2,004
+24% +$30.7K ﹤0.01% 1911
2023
Q1
$188K Sell
8,379
-1,232
-13% -$27.6K ﹤0.01% 1827
2022
Q4
$202K Hold
9,611
﹤0.01% 1862
2022
Q3
$237K Buy
9,611
+141
+1% +$3.48K ﹤0.01% 1790
2022
Q2
$229K Buy
9,470
+2,177
+30% +$52.6K ﹤0.01% 1820
2022
Q1
$188K Sell
7,293
-504
-6% -$13K ﹤0.01% 1966
2021
Q4
$242K Buy
+7,797
New +$242K ﹤0.01% 1903
2021
Q1
Sell
-7,649
Closed -$208K 1623
2020
Q4
$208K Buy
+7,649
New +$208K 0.01% 1433